ArticleScientific reports2026
Proteomic atlas of human peritoneal tissue.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Peritoneal carcinomatosis occurs when the parietal and visceral peritoneum are involved with multifocal metastatic tumors, most commonly arising from abdominopelvic organ sites. The prevailing model of peritoneal carcinomatosis sees the peritoneal lining as the ‘soil’ onto which metastatic cancer cells attach and grow. Molecular methods to assess the functional status of this microenvironment have not been well developed. To address this gap, we analyzed the protein composition of peritoneal tissue using liquid chromatography-tandem mass spectrometry on both fresh frozen and formalin-fixed, paraffin-embedded benign tissue (FFPE) samples, employing an ultra-high-resolution timsTOF mass spectrometer. The protein yield in peritoneal tissue was lower than that observed from similar studies of other visceral organ tissues. Extracellular matrix (ECM) proteins were present in high abundance and may be contributory to cancer cell attachment and invasion in peritoneal carcinomatosis. We further quantified key signal transduction and metabolic proteins known to contribute to cancer progression, along with defined tumor suppressors and oncoproteins. Our findings represent a baseline catalog of the proteomic composition of the peritoneal lining, as a comparison dataset for future studies focused on alterations in pathologic states such as peritoneal carcinomatosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.